Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-06-11
1996-09-03
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
546 91, 546132, 514304, A61K 3144, C07D21320
Patent
active
055524079
ABSTRACT:
Methylecgonidine (MEG; anhydroecgonine methylester), is produced when cocaine base ("crack") is heated. MEG alone and in combination with cocaine was tested for action on isolated tracheal rings stimulated to contact with acetylcholine. At micromolar concentrations, cocaine sensitized tracheal rings, increasing both the potency and efficacy of acetylcholine-induced contraction. Surprisingly, MEG, at nanomolar concentrations and above, non-competitively and irreversibly antagonized acetylcholine-induced contraction independently of the actions of cocaine. MEG also displayed antihistaminic activity. Therefore, MEG and anticholinergically active derivatives or analogues thereof are useful in the prevention or treatment of a disease or disorder treatable by an antimuscarinic anticholinergic agent, an anti-histaminic agent or a spasmolytic agent, in particular bronchoconstriction in a number of pulmonary diseases such as asthma.
REFERENCES:
patent: 4467095 (1984-08-01), Treves et al.
Chemical Abstracts, vol. 51, No. 21, Abstract 16501e, h, Nov. 10, 1957.
Chemical Abstracts, vol. 57, No. 3, Abstract 3390g, Aug. 6, 1962, Zirkle et al.
Chemical Abstracts, vol. 53, No. 1, Abstract 1327h, Jan. 10, 1959, Zaugg et al.
Leete, "Biosynthesis of the Pyrrolidine Rings of Cocaine and Cuscohygrine from [5-.sup.14 C]Ornithine via a Symmetrical Intermediate", J. Am. Checm. Soc. 104:1403-1408 (1982).
H. S. Orer et al., "Antagonism of Acetylcholine Action in Guinea-Pig Tracheal Smooth Muscle and Epithelium by Pirenzepine, 4-DAMP and Atropine" Arch. Int. Pharmacodyn. 305:45-54 (1990).
T. Inaba, "Cocaine: Pharmacokinetics and biotransformation in man" Can. J. Physiol. Pharmacol. 67:1154-1157 (1989).
R. W. Foltin et al., "Demonstration of naturalistic methods for cocaine smoking by human volunteers" Drug Alcohol Depend. 26:145-154 (1990).
Davies, H. M. L., "Novel 2-substituted cocaine analogs: binding properties at dopamine transport sites in rat striatum" Eur. J. Pharmacol. 244:93-97 (1993).
J. P. Boni et al., "Pyrolysis of Cocaine Free Base" FASEB J. 2(5) 1988, abstr. 4891.
B. R. Martin et al., "Pyrolysis and Volatilization of Cocaine" J. Anal. Toxicol. 13:158-162 (1989).
P. Jacob III et al., "A Pyrolysis Product, Anhydroecgonine Methyl Ester (Methylecgonidine), is in the Urine of Cocaine Smokers" J. Anal. Toxicol. 14:353-357 (1990).
W. T. Lowry et al., "Identification of Two Novel Cocaine Metabolites in Bile by Gas Chromatography and Gas Chromatography/Mass Spectrometry in a Case of Acute Intravenous Cocaine Overdose" J. Anal. Toxicol. 3:91-95 (1979).
Carroll et al., "Probes for the Cocaine Receptor. Potentially Irreversible Ligands for the Dopamine Transporter" J. Med. Chem. 35:1813-1817 (1992).
Cereda et al., "Synthesis and Biological Evaluation of New Antimuscarinic Compounds with Amidine Basic Centers. A Useful Bioisosteric Replacement of Classical Cationic Heads" J. Med. Chem. 33:2108-2113 (1990).
J. Sharkey et al., "Cocaine Inhibits Muscarinic Cholinergic Receptors in Heart and Brain" J. Pharmacol. Exp. Ther. 246:1048-1052 (1988).
Meyer et al., "Effects of Benzolytropine and Tropacocaine on Several Cholinergic Processes in the Rat Brain" J. Pharmacol. Exp. Ther. 254:584-590 (1988).
R. F. H. Taylor et al., "Betel-nut chewing and asthma" Lancet 339:1134-1136 (1992).
H. A. N. El-Fawal et al., "The Biventer Cervicis Nerve-Muscle Preparation of Adult Hens: Effects of Phenyl Saligenin Phosphate Administration" Neurotoxicology 9:625-636 (1988).
Gross, N. J., "Ipratropium Bromide" New Eng. J. Med. 319:486-494 (1988).
M. W. Fischman et al., "A Comparison of the Subjective and Cardiovascular Effects of Cocaine and Lidocaine in Humans" Pharmacol. Biochem. Behav. 18:123-127 (1983).
Deckers, W., "The chemistry of new derivatives of tropane alkaloids and the pharmacokinetics of a new quarternary compound" Postgrad. Med. J. 51 (Suppl. 7):76-81 (1975).
Chen Lung C.
El-Fawal Hassan A. N.
Graefe John F.
Shojaie Jalil
Wood Ronald W.
Davis Zinna N.
Ivy C. Warren
New York University Medical Center
LandOfFree
Anhydroecgonine compounds and their use as anticholinergic agent does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anhydroecgonine compounds and their use as anticholinergic agent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anhydroecgonine compounds and their use as anticholinergic agent will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1950128